Surface-specific bone formation effects of osteoporosis pharmacological treatments

Clinical Reviews in Bone and Mineral Metabolism

Volumn 6, Issue 1-2, 2008, Pages 62-69

  Allen, Matthew R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bisphosphonates; Estrogen hormone replacement therapy; Parathyroid hormone; Selective estrogen receptor modulators (SERMs)

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ESTROGEN; HORMONE; IBANDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

BIOMECHANICS; BONE MARROW BIOPSY; BONE REMODELING; CORTICAL BONE; DRUG INTERMITTENT THERAPY; ESTROGEN THERAPY; FRAGILITY FRACTURE; HORMONE SUBSTITUTION; HUMAN; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PERIOSTEUM; REVIEW; RISK REDUCTION; TRABECULAR BONE; TREATMENT OUTCOME;

EID: 58149103067     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12018-008-9022-6     Document Type: Review

References (90)

1. SR Cummings DB Karpf F Harris HK Genant 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs Am J Med 112 4 281 9
2. R Marcus M Wong H Heath 3rd JL Stock 2002 Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint Endocr Rev 23 1 16 37
3. C Rosen J Bilezikian 2001 Anabolic therapy for osteoporosis J Clin Endocrinol Metab 86 3 957 64
4. BL Riggs AM Parfitt 2005 Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling J Bone Miner Res 20 2 177 84
5. MR Allen JM Hock DB Burr 2004 Periosteum: biology, regulation, and response to osteoporosis therapies Bone 35 5 1003 12
6. M Bliziotes JD Sibonga RT Turner E Orwoll 2006 Periosteal remodeling at the femoral neck in nonhuman primates J Bone Miner Res 21 7 1060 7
7. E Orwoll 2003 Toward an expanded understanding of the role of the periosteum in skeletal health J Bone Miner Res 18 6 949 54
8. R Balena MS Shih AM Parfitt 1992 Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women J Bone Miner Res 7 12 1475 82
9. H Alhlborg O Johnell C Turner G Rannevik 2003 Bone loss and bone size after menopause N Engl J Med 349 4 327 34
10. TJ Beck CB Ruff WW Scott Jr CC Plato 1992 Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data Calcif Tissue Int 50 1 24 9
11. Burr DB, Turner CH. Biomechanics of bone. In: Favus M editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. Washington DC: American Society for Bone and Mineral Research; 2003. p. 58-64.
12. RT Turner BL Riggs TC Spelsberg 1994 Skeletal effects of estrogen Endocr Rev 15 3 275 300
13. RT Turner KS Hannon LM Demers J Buchanan 1989 Differential effects of gonadal function on bone histomorphometry in male and female rats J Bone Miner Res 4 4 557 63
14. GK Wakley GL Evans RT Turner 1997 Short-term effects of high dose estrogen on tibiae of growing male rats Calcif Tissue Int 60 1 37 42
15. CJ Lees TC Register CH Turner T Wang 2002 Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys Menopause 9 5 320 8
16. R Recker T Coble A Burshell A Lombardi 2001 Effect of alendronate and estrogen replacement on periosteal bone formation in postmenopausal women J Bone Miner Res 16 1176
17. MR Allen H Follet M Khurana DB Burr 2006 Anti-remodeling agents influence osteoblast activity differently in modeling- and remodeling-associated bone formation Calcif Tissue Int 79 4 255 61
18. S Bare S Recker R Recker D Kimmel 2005 Influence of alendronate on periosteal and endocortical bone formation in the illium of osteoporotic women J Bone Miner Res 20 SA414
19. T Mashiba T Hirano CH Turner MR Forwood 2000 Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib J Bone Miner Res 15 4 613 20
20. S Komatsubara S Mori T Mashiba J Li 2004 Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib J Bone Miner Res 19 6 999 1005
21. MR Allen S Reinwald DB Burr 2008 Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment Calcif Tissue Int 82 5 354 60
22. Y Yoshida A Moriya K Kitamura M Inazu 1998 Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction J Bone Miner Res 13 6 1011 22
23. MH Lafage R Balena MA Battle M Shea 1995 Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study J Clin Invest 95 5 2127 33
24. D Bikle E Morey-Holton S Doty P Currier 1994 Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage J Bone Miner Res 9 11 1777 87
25. K Iwata J Li H Follet RJ Phipps 2006 Bisphosphonates suppress periosteal osteoblast activity independent of resorption in rat femur and tibia Bone 39 5 1053 8
26. M Nakamura N Udagawa S Matsuura M Mogi 2003 Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption Endocrinology 144 12 5441 9
27. AM Parfitt 2002 Parathyroid hormone and periosteal bone expansion J Bone Miner Res 17 10 1741 3
28. DW Dempster F Cosman ES Kurland H Zhou 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study J Bone Miner Res 16 10 1846 53
29. AB Hodsman M Kisiel JD Adachi LJ Fraher 2000 Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis Bone 27 2 311 8
30. Y Jiang JJ Zhao BH Mitlak O Wang 2003 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure J Bone Miner Res 18 11 1932 41
31. D Dempster H Zhou F Cosman J Nieves 2001 PTH treatment directly stimulates bone formation in cancellous and cortical bone in humans J Bone Miner Res 16 Supp 1 S179
32. R Lindsay H Zhou F Cosman J Nieves 2007 Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium J Bone Miner Res 22 4 495 502
33. M Arlot PJ Meunier G Boivin L Haddock 2005 Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters J Bone Miner Res 20 7 1244 53
34. T Hirano DB Burr RL Cain JM Hock 2000 Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34) Calcif Tissue Int 66 6 456 60
35. T Hirano DB Burr CH Turner M Sato 1999 Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits J Bone Miner Res 14 4 536 45
36. T Mashiba DB Burr CH Turner M Sato 2001 Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits Bone 28 5 538 47
37. DB Burr 1993 Remodeling and the repair of fatigue damage Calcif Tissue Int 53 Suppl 1 S75 80 discussion S80-1
38. E Seeman PD Delmas 2006 Bone quality-the material and structural basis of bone strength and fragility N Engl J Med 354 21 2250 61
39. Martin RB, Burr DB, Sharkey NA. Skeletal tissue mechanics. New York: Springer; 1998.
40. SM Tommasini P Nasser B Hu KJ Jepsen 2008 Biological co-adaptation of morphological and composition traits contributes to mechanical functionality and skeletal fragility J Bone Miner Res 23 2 236 46
41. KL Bell N Loveridge PC Lindsay M Lunt 1997 Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone J Bone Miner Res 12 8 1231 40
42. S Vedi KL Bell N Loveridge N Garrahan 2003 The effects of hormone replacement therapy on cortical bone in postmenopausal women. A histomorphometric study Bone 33 3 330 4
43. EF Eriksen F Melsen E Sod I Barton 2002 Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis Bone 31 5 620 5
44. T Dufresne P Chmielewski M Manhart T Johnson 2003 Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography Calcif Tissue Int 73 5 423 32
45. P Roschger S Rinnerthaler J Yates GA Rodan 2001 Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women Bone 29 2 185 91
46. F Itoh M Kojima H Furihata-Komatsu S Aoyagi 2002 Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate J Bone Miner Res 17 3 534 43
47. SY Smith RR Recker M Hannan R Muller 2003 Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys Bone 32 1 45 55
48. T Mashiba S Hui CH Turner S Mori 2005 Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs Calcif Tissue Int 77 3 180 5
49. M Sato M Westmore YL Ma A Schmidt 2004 Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity J Bone Miner Res 19 4 623 9
50. D Burr T Hirano C Turner C Hotchkiss 2001 Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys J Bone Miner Res 16 157 65
51. RW Boyce CL Paddock AF Franks ML Jankowsky 1996 Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone J Bone Miner Res 11 5 600 13
52. ZH Han S Palnitkar DS Rao D Nelson 1997 Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss J Bone Miner Res 12 4 498 508
53. R Recker J Lappe KM Davies R Heaney 2004 Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients J Bone Miner Res 19 10 1628 33
54. RS Weinstein AM Parfitt R Marcus M Greenwald 2003 Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women Osteoporos Int 14 10 814 22
55. B Borah TE Dufresne PA Chmielewski TD Johnson 2004 Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography Bone 34 4 736 46
56. G Bevill SK Eswaran A Gupta P Papadopoulos 2006 Influence of bone volume fraction and architecture on computed large-deformation failure mechanisms in human trabecular bone Bone 39 6 1218 25
57. EG Lufkin HW Wahner WM O'Fallon SF Hodgson 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen Ann Intern Med 117 1 1 9
58. KM Prestwood M Gunness DB Muchmore Y Lu 2000 A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women J Clin Endocrinol Metab 85 6 2197 202
59. BL Riggs J Jowsey RS Goldsmith PJ Kelly 1972 Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis J Clin Invest 51 7 1659 63
60. S Vedi JE Compston 1996 The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women Bone 19 5 535 9
61. EF Eriksen B Langdahl A Vesterby J Rungby 1999 Hormone replacement therapy prevents osteoclastic hyperactivity: a histomorphometric study in early postmenopausal women J Bone Miner Res 14 7 1217 21
62. G Khastgir J Studd N Holland J Alaghband-Zadeh 2001 Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study J Clin Endocrinol Metab 86 1 289 95
63. S Patel M Pazianas J Tobias TJ Chambers 1999 Early effects of hormone replacement therapy on bone Bone 24 3 245 8
64. S Vedi DW Purdie P Ballard S Bord 1999 Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy Osteoporos Int 10 1 52 8
65. SM Ott A Oleksik Y Lu K Harper 2002 Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women J Bone Miner Res 17 2 341 8
66. KD Ham CS Carlson 2004 Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys J Bone Miner Res 19 5 823 9
67. MR Allen K Iwata M Sato DB Burr 2006 Raloxifene enhances vertebral mechanical properties independent of bone density Bone 39 1130 5
68. PM Chavassieux ME Arlot C Reda L Wei 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis J Clin Invest 100 6 1475 80
69. JJ Stepan DB Burr I Pavo A Sipos 2007 Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis Bone 41 3 378 85
70. R Recker P Masarachia A Santora T Howard 2005 Trabecular bone microarchitecture after alendronate treatment of osteoporotic women Curr Med Res Opin 21 2 185 94
71. RR Recker RS Weinstein CH Chesnut 3rd RC Schimmer 2004 Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study Osteoporos Int 15 3 231 7
72. RR Recker PD Delmas J Halse IR Reid 2008 Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure J Bone Miner Res 23 1 6 16
73. R Balena BC Toolan M Shea A Markatos 1993 The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates J Clin Invest 92 6 2577 86
74. MC Monier-Faugere Z Geng EP Paschalis Q Qi 1999 Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties J Bone Miner Res 14 10 1768 78
75. MR Allen DB Burr 2007 Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment J Bone Miner Res 22 11 1759 65
76. MR Allen K Iwata R Phipps DB Burr 2006 Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate Bone 39 4 872 9
77. MR Forwood DB Burr Y Takano DF Eastman 1995 Risedronate treatment does not increase microdamage in the canine femoral neck Bone 16 6 643 50
78. S Komatsubara S Mori T Mashiba M Ito 2003 Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra J Bone Miner Res 18 3 512 20
79. T Mashiba CH Turner T Hirano MR Forwood 2001 Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles Bone 28 5 524 31
80. M Allen D Burr 2006 Parathyroid hormone and bone biomechanics Clin Rev Bone Miner Metab 4 4 259 68
81. DB Burr 2005 Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size Curr Osteoporos Rep 3 1 19 24
82. H Dobnig RT Turner 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells Endocrinology 136 8 3632 8
83. AB Hodsman BM Steer 1993 Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces Bone 14 3 523 7
84. J Reeve PJ Meunier JA Parsons M Bernat 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial Br Med J 280 6228 1340 4
85. T Miki K Nakatsuka H Naka H Masaki 2004 Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment J Bone Miner Metab 22 6 569 76
86. CP Jerome CS Johnson HT Vafai KC Kaplan 1999 Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis) Bone 25 3 301 9
87. PD Delmas P Vergnaud ME Arlot P Pastoureau 1995 The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate-is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16 6 603 10
88. L Zhang HE Takahashi J Inoue T Tanizawa 1997 Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles Bone 21 6 501 6
89. CP Jerome DB Burr T Van Bibber JM Hock 2001 Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis) Bone 28 2 150 9
90. M Sato M Westmore J Clendenon S Smith 2000 Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques Osteoporos Int 11 10 871 80